Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Compliance
研究概览
简要总结
Survivorship programs have become an integral component of modern cancer care programs. In Canada, there has been tremendous success for survivorship programs for breast, prostate, and colorectal cancer, however lung cancer survivorship programs have not been widely developed. The complexity of the disease, high mortality, short survival times, high cost of surveillance, and patient habits have traditionally been barriers against the success of lung cancer survivorship programs. The investigator proposes a feasibility study to pilot a novel intervention titled Breathe Anew, which will aim to identify and overcome the barriers to the design and implementation of a lung cancer survivorship program. The investigator has assembled a multi-disciplinary team of experts and lung cancer survivors who will develop the Breathe Anew survivorship intervention. The intervention will be vetted using an integrated knowledge translation approach, which will involve members of the target population, primarily patients who previously underwent lung resection, to modify the intervention and ensure acceptability. After Breathe Anew has been designed, it will be tested in a pilot study of 50 patients to ensure its feasibility and determine its cost. The ultimate goal of this feasibility study is to lay the groundwork for a subsequent comparative trial to evaluate the impact of Breathe Anew on patient-important outcomes including health related quality and length of life and postoperative complications.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 years or older
- •All patients at St. Joseph's Healthcare Hamilton who received lung resection for Stage I, Stage II, or Stage IIIa Non-Small Cell Lung Cancer are eligible to enroll.
- •Owns a smart device
排除标准
- •Patients who received lung resection for Stage IIIb or IV Non-Small Cell Lung Cancer
- •Patients with affected mobility (walker, wheelchair)
- •Patients who use oxygen at home
结局指标
主要结局
Compliance
时间窗: 12 months
The feasibility of Breath Anew, as measured by a rate of compliance of \>70% with all the components of the intervention.
次要结局
- Accrual Rate(12 months)
- Cost Per Patient(12 months)
- Patient-Reported Satisfaction(12 months)
研究者
Wael Hanna
Associate Professor of Surgery
St. Joseph's Healthcare Hamilton
